UCP1 and Insulin resistance: Olanzapine induces insulin resistance (IR) by suppressing brown adipose tissue thermogenesis, damping expression of mitochondria uncoupling protein-1 and inhibiting glucose transporters, leading to impaired glucose uptake and decreased response to insulin [30].